2021-10-04 Comments Off on Ruxolitinib Cream Meets Endpoints in Phase 3 Vitiligo Trial Ruxolitinib Cream Meets Endpoints in Phase 3 Vitiligo Trial A topical cream formulation of the JAK inhibitor ruxolitinib was